GLYCYRRHIZA GLABRA

GLYCYRRHIZA GLABRA was reported 3903 times

GLYCYRRHIZA GLABRA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPARENT MINERALOCORTICOID EXCESS 2 0.0345
1 BLOOD ALDOSTERONE DECREASED 1 0.0132
2 RENIN DECREASED 1 0.0118
3 KL-6 INCREASED 1 0.0044
4 RECTAL SPASM 1 0.0043
5 OESTRADIOL INCREASED 1 0.0033
6 TRICHOGLOSSIA 1 0.0024
7 HYPERTENSIVE ENCEPHALOPATHY 1 0.0017
8 CHOLANGITIS ACUTE 1 0.0013
9 OBSTRUCTIVE PANCREATITIS 1 0.0013
10 LYMPHANGIOSIS CARCINOMATOSA 1 0.0010
11 NEPHROSCLEROSIS 1 0.0009
12 VESTIBULAR DISORDER 1 0.0008
13 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
14 CHRONIC FATIGUE SYNDROME 1 0.0007
15 PRECANCEROUS SKIN LESION 1 0.0007
16 TINEA PEDIS 1 0.0006
17 METABOLIC ALKALOSIS 1 0.0006
18 PRODUCT COUNTERFEIT 1 0.0006
19 HYPERTENSIVE HEART DISEASE 1 0.0005
20 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 1 0.0005
21 CHOLESTATIC LIVER INJURY 1 0.0004
22 TEMPERATURE REGULATION DISORDER 1 0.0004
23 MALABSORPTION 2 0.0004
24 LOSS OF EMPLOYMENT 1 0.0003
25 EPIGASTRIC DISCOMFORT 1 0.0003
26 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
27 CONGESTIVE CARDIOMYOPATHY 1 0.0002
28 RHINITIS ALLERGIC 1 0.0002
29 SKIN TOXICITY 1 0.0002
30 CHOLECYSTITIS ACUTE 1 0.0002
31 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
32 ACUTE CORONARY SYNDROME 1 0.0001
33 VITAMIN D DECREASED 1 0.0001
34 ANAL INCONTINENCE 1 0.0001
35 INCREASED TENDENCY TO BRUISE 1 0.0001
36 TOXIC SKIN ERUPTION 1 0.0001
37 OESOPHAGITIS 1 0.0001
38 IMPAIRED DRIVING ABILITY 1 0.0001
39 GASTRIC HAEMORRHAGE 1 0.0001
40 ANOREXIA 1 0.0001
41 PULMONARY CONGESTION 1 0.0001
42 QUALITY OF LIFE DECREASED 1 0.0001
43 GINGIVAL BLEEDING 1 0.0001
44 HEPATOCELLULAR INJURY 1 0.0001
45 METASTASES TO BONE 1 0.0001
46 COAGULOPATHY 1 0.0001
47 EOSINOPHILIA 1 0.0001
48 PHOTOPHOBIA 1 0.0001
49 GASTRIC ULCER 1 0.0001
50 SLEEP APNOEA SYNDROME 1 0.0001
51 MENORRHAGIA 1 0.0001
52 IMPAIRED WORK ABILITY 1 0.0000
53 FAECES DISCOLOURED 1 0.0000
54 RASH MACULO-PAPULAR 1 0.0000
55 FIBROMYALGIA 1 0.0000
56 GASTRIC CANCER 1 0.0000
57 DEAFNESS 1 0.0000
58 ANHEDONIA 1 0.0000
59 MENTAL STATUS CHANGES 1 0.0000
60 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
61 URINARY INCONTINENCE 1 0.0000
62 GASTROINTESTINAL DISORDER 3 0.0000
63 BLOOD POTASSIUM DECREASED 1 0.0000
64 DRUG INTERACTION 5 0.0000
65 HYPOTHYROIDISM 1 0.0000
66 CHOLELITHIASIS 1 0.0000
67 DYSURIA 1 0.0000
68 RHABDOMYOLYSIS 1 0.0000
69 THERAPY NON-RESPONDER 1 0.0000
70 HYPOKALAEMIA 1 0.0000
71 INTERSTITIAL LUNG DISEASE 1 0.0000
72 HYPOGLYCAEMIA 1 0.0000
73 FLATULENCE 1 0.0000
74 SURGERY 1 0.0000
75 STOMATITIS 1 0.0000
76 VERTIGO 1 0.0000
77 HYPERTENSION 3 0.0000
78 BRONCHITIS 1 0.0000
79 ACUTE KIDNEY INJURY 2 0.0000
80 CARDIAC FAILURE 1 0.0000
81 RENAL IMPAIRMENT 1 0.0000
82 NEUROPATHY PERIPHERAL 1 0.0000
83 MIGRAINE 1 0.0000
84 CHEST DISCOMFORT 1 0.0000
85 ABDOMINAL DISTENSION 1 0.0000
86 HAEMORRHAGE 1 0.0000
87 PALPITATIONS 1 0.0000
88 DISEASE PROGRESSION 1 0.0000
89 VISUAL IMPAIRMENT 1 0.0000
90 CONFUSIONAL STATE 1 0.0000
91 TREMOR 1 0.0000
92 TOXICITY TO VARIOUS AGENTS 1 0.0000
93 PYREXIA 2 0.0000
94 MUSCLE SPASMS 1 0.0000
95 CHEST PAIN 1 0.0000
96 HYPERSENSITIVITY 1 0.0000
97 ASTHENIA 2 0.0000
98 HYPOTENSION 1 0.0000
99 DEPRESSION 1 0.0000
100 FATIGUE 3 0.0000
101 ANXIETY 1 0.0000
102 CONDITION AGGRAVATED 1 0.0000
103 PNEUMONIA 1 0.0000
104 MALAISE 1 0.0000
105 DIZZINESS 1 0.0000
106 DYSPNOEA 1 0.0000
107 HEADACHE 1 0.0000
108 DIARRHOEA 1 0.0000
109 DRUG INEFFECTIVE 2 0.0000
110 NAUSEA 1 0.0000